Beneficial effects of fetal maternal microchimerism on the activated haplo-identical peripheral blood stem cell treatment for cancer

Cytotherapy

Volumn 10, Issue 4, 2008, Pages 331-339

  Yu, J ^a   Ren, X ^a   Cao, S ^a   Li, H ^a   Hao, X ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Fetal maternal microchimerism; Haplo identical; Immunotherapy; Peripheral blood stem cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTOKINE; GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL MATERNAL MICROCHIMERISM; HUMAN; LIVING DONOR; MALE; MICROCHIMERISM; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOLID TUMOR; SURVIVAL TIME; TH1 CELL; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 47249158110     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802061146     Document Type: Article

References (30)

1. Vriesendorp, HM. (2003) Aims of conditioning. Exp Hematol, 31, pp. 844-854.
2. Childs, R., Chernoff, A. Contentin, N. et al. (2000) Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med, 343, pp. 750-758.
3. Eibl, B., Schwaighofer, H. Nachbaur, D. et al. (1996) Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood, 88, pp. 1501-1508.
4. Ueno, NT, Rondon, G. Mirza, NQ et al. (1998) Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer. J Clin Oncol, 16, pp. 986-993.
5. Bregni, M., Dodero, A. Peccatori, J. et al. (2002) Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood, 99, pp. 4234-4236.
6. Carella, AM, Beltrami, G. Lerma, E. et al. (2002) Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer. Cancer Treat Res, 110, pp. 101-112.
7. Bay, JO, Fleury, J. Choufi, B. et al. (2002) Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: Results of five patients. Bone Marrow Transplant, 30, pp. 95-102.
8. Bregni, M., Bernardi, M. Ciceri, F. et al. (2004) Allogeneic stem cell transplantation for the treatment of advanced solid tumors. Springer Semin Immunopathol, 26, pp. 95-108.
9. Kami, M., Makimoto, A. Heike, Y. et al. (2004) Reduced-intensity hematopoietic stem cell transplantation (RIST) for solid malignancies. Jpn J Clin Oncol, 34, pp. 707-716.
10. Mielcarek, M., Martin, PJ Leisenring, W. et al. (2003) Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood, 102, pp. 756-762.
11. Aversa, F. and Martelli, MF. (2004) Transplantation of haplo-identically mismatched stem cells for the treatment of malignant diseases. Springer Semin Immunopathol, 26, pp. 155-168.
12. Waller, EK. (2004) Cellular immunotherapy and cancer. Semin Oncol, 31, pp. 87-90.
13. Ren, X., Yu, J. Cao, S. et al. (2007) Antitumor effect of IL-2 activated HLA haplo-identical peripheral blood stem cells in metastatic solid tumor treatment. Cancer Biother Radiopharm, 22, pp. 223-234.
14. Ichinohe, T., Teshima, T. Matsuoka, K. et al. (2005) Fetal-maternal microchimerism: Impact on hematopoietic stem cell transplantation. Curr Opin Immunol, 17, pp. 546-552.
15. Teshima, T., Matsuoka, K. and Ichinohe, T. (2006) Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation. Arch Immunol Ther Exp, 54, pp. 165-172.
16. Schlitt, HJ, Hundrieser, J. Hisanaga, M. et al. (1994) Patterns of donor-type microchimerism after heart transplantation. Lancet, 343, pp. 1469-1471.
17. + cells of patients after liver transplantation. Blood, 96, pp. 763-767.
18. Bateman, AC, Turner, SJ Theaker, JM et al. (1999) Polymerase chain reaction based human leukocyte antigen genotyping for the investigation of suspected gastrointestinal biopsy contamination. Gut, 45, pp. 259-263.
19. Garavito, G., Klein, D. Denis, M. et al. (2002) Real-time sequence-specific primer polymerase chain reaction amplification of HLA class II alleles: A novel approach to analyze microchimerism. Transplantation, 73, pp. 822-825.
20. Carter, AS, Cerundolo, L. Bunce, M. et al. (1999) Nested polymerase chain reaction with sequence-specific primers typing for HLA-A, -B, and -C alleles: Detection of microchimerism in DR-matched individuals. Blood, 94, pp. 1471-1477.
21. Carter, AS, Bunce, M. Cerundolo, L. et al. (1998) Detection of microchimerism after allogeneic blood transfusion using nested polymerase chain reaction amplification with sequence-specific primers (PCR-SSP): A cautionary tale. Blood, 92, pp. 683-689.
22. Shimazaki, C., Ochiai, N. Uchida, R. et al. (2003) Non-T-cell-depleted HLA haplo-identical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood, 101, pp. 3334-3336.
23. van Rood, JJ, Loberiza Jr, FR Zhang, MJ et al. (2002) Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haplo-identical sibling. Blood, 99, pp. 1572-1577.
24. Miller, AB, Hoogstraten, B. Staquet, M. et al. (1981) Reporting results of cancer treatment. Cancer, 47, pp. 207-214.
25. Starzl, TE, Demetris, AJ Murase, N. et al. (1992) Cell migration, chimerism, and graft acceptance. Lancet, 339, pp. 1579-1582.
26. Starzl, TE. (2004) Chimerism and tolerance in transplantation. Proc Natl Acad Sci USA, 101, pp. 14607-14614.
27. Hisanaga, M., Hundrieser, J. Boker, K. et al. (1996) Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation, 61, pp. 40-45.
28. Noris, M., Cugini, D. Casiraghi, F. et al. (2001) Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation. J Am Soc Nephrol, 12, pp. 2815-2826.
29. Yoshihara, T., Morimoto, A. Inukai, T. et al. (2004) Non-T-cell-depleted HLA haplo-identical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies. Bone Marrow Transplant, 34, pp. 373-375.
30. Tokita, K., Terasaki, P. Maruya, E. et al. (2001) Tumour regression following stem cell infusion from daughter to microchimeric mother. Lancet, 358, pp. 2047-2048.